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1. Introduction
One of the main challenges of pharmaceutical tech-
nology at the beginning of the 21st century, which is
the great period of biotechnology, is the formulation
of biopharmaceuticals (proteins, peptides, nucleic
acids, living cells, viral particles and vaccines). These
objects are generally very sensitive to the physical
and chemical impacts of their environment [1]. Solid
dosage forms are preferred to liquid ones from sta-
bility, dose accuracy, shipping, handling, and patient-
compliance points of view; however, drying is a
limiting factor in their formulation. After the biotech-
nological processes, gentle removal of the com-
monly applied water would be desirable to keep the
structure of bio-drugs unaltered [2].
Electrospinning (electrostatic spinning, ES) is a
remarkably simple and efficient technique to gener-
ate fine polymeric fibers in submicron – and nano –
scale from polymer solutions (or melts) using high
electric voltage [3]. Electrospinning provides an
extremely rapid (less than 0.1 s [4]) and very gentle
drying step at ambient temperature due to the direct
interactions between the electrostatic energy and the
working fluids and to the huge surface area of the
fluid jets during the bending and whipping processes.
This fiber forming process has been primarily devel-
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© BME-PToped in the textile industry [5–8], but in the recent
years, applications have been published also in var-
ious biomedical fields such as wound dressing [9],
wound healing [10], sterile filtration [11], tissue
engineering [12, 13] and drug delivery [14–19].
In former studies bioactive ingredients such as pro-
teins and DNA have been embedded successfully in
nanofibers mainly for tissue engineering purposes,
while living prokaryotic cells were encapsulated by
this technique mainly for industrial application in
bioreactors utilizing their metabolic activity [20–
22]. Zussman [23] has recently reviewed the prepa-
ration methods of electrospun polymer fibers
encapsulating cells and their potential applications.
Salalha et al. [24] showed that Escherichia coli and
Staphylococcus albus remained viable after electro-
spinning process and retained their viability in poly  -
vinyl alcohol (PVA) matrix for at least 3 months
when the bacteria-containing electrospun webs
were stored at –20 and –55°C. Lopez-Rubio et al.
[25] incorporated living probiotic bacteria (B. ani-
malis Bb12) into PVA nanofibers applying co-elec-
trospinning and the cells remained viable after
40 days at room temperature and 130 days at 4 and
–20°C under refrigeration. Henceforth they encap-
sulated B. animalis Bb12 into protein- and carbohy-
drate-based microcapsules using electrospraying
[26]. Similarly, Heunis et al. [27] and Fung et al.
[28] embedded Lactobacillus bacteria into polymer
nanofibers with moderate survival rate (2% [27]
and 1–10% [28]).
Lactobacillus acidophilus is one of the most widely
investigated and used species especially in the field
of dairy industry and it is an important part of nor-
mal human bacterial flora usually located in mouth,
gastrointestinal tract and the urinary and genital tract
of females [29, 30]. The most common vaginal dis-
ease (at ages 14–49), the bacterial vaginosis (poly  -
microbial syndrome caused by an imbalance of nor-
mal vaginal micro flora) is in connection with the
lack of Lactobacillus bacteria and its substitution by
exogenous bacteria [31]. Vaginal pH rises up over
4.5 during bacterial vaginosis and Lactobacillus
bacteria may disappear almost completely [32]. Cur-
ing of this disorder is a considerable challenge of the
healthcare worldwide because about one third of
females are affected (29% in the United States [33]).
In normal vaginal microbiota, a huge number of
Lactobacillus bacteria exist, which prevent the col-
onization and proliferation of pathogenic microor-
ganisms through several ways, such as competition
for nutrients and adherence, production of H2O2[34],
bacteriocins [35] and lactic acid, which is mainly
responsible for the protective acidic pH of the vagina
[36]. Several clinical studies showed that intra-
vaginal administration of Lactobacillus acidophilus
resulted in a significantly increased number of
recoveries compared to treatments with placebo,
acetic acid or no treatment [37–40]. Furthermore, a
recent review drew attention to the increased impor-
tance of probiotic treatment for prevention of bacte-
rial vaginosis so that more serious complications
can be avoided [41]. The efficacy of standard antibi-
otic treatments has been decreasing (because of the
spreading of resistant bacteria strains and due to the
increasing refusal of antibiotics by patients). There-
fore, new, effective, readily accessible and econom-
ical lactobacilli-based probiotic therapies are badly
needed [41]. It meets the purpose of this work since
water-based electrospinning is a simple, scalable
and continuous technology with very low energy con-
sumption [8, 17, 42]. Furthermore, development of
effective drug delivery systems for living cells and
other biopharmaceuticals is a general need of phar-
maceutical technology owing to the newly appear-
ing biomedicals [43].
The aim of this work was to develop an electrospin-
ning-based method for encapsulation of Lactobacil-
lus acidophilus (LBA) and to investigate the appli-
cability of electrospinning technology for preparing
vaginal drug delivery systems in the form of biohy-
brid nanowebs (BNW)  for curing of bacterial vagi-
nosis.
2. Experimental section
2.1. Materials
Lactobacillus acidophilus (Strain number: B1075)
was kindly provided by National Collection of Agri-
cultural and Industrial Microrganisms (Budapest,
Hungary).
Polyvinyl pyrrolidone (PVP) with two different
chain lengths (molecular weight: PVP K30:
~50 000 Da, PVP K90: ~1 200 000 Da), kindly pro-
vided by BASF (Ludwigshafen, Germany) and poly  -
vinyl alcohol (PVA), purchased from Fluka (Buchs,
Switzerland, molecular weight: 130 000 Da), were
used as polymer matrices. Solvent was distilled
water.
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polymer solution
The optimal concentration of the polymer solutions
was determined without LBA. The polymers were
added into 10 mL of purified water and stirred by
ARE magnetic stirrer (VELP Scientifica, Usmate,
Italy) at 600 rpm and 50°C until complete dissolu-
tion was achieved. The mass percents of polymer
solutions were as follows: PVA 130 000 and PVP
K90: 5, 10, 15, 20%; PVP K30: 20, 25, 30, 35, 40,
45, 50%. The solutions and the collected electrospun
materials were investigated with a rheometer, and
by optical and electron microscopy, respectively.
2.3. Preparation of bacterial suspensions and
bacteria-containing polymer suspensions
Stock culture was subcultured in MRS agar (LabM,
Bury, United Kingdom). The MRS agar was freshly
prepared and sterilized. According to the instruc-
tions of the manufacturer 70 g of MRS agar powder
was added to 1 L of deionized water. The system was
heated and mixed properly and after total dissolu-
tion it was autoclaved at 121°C. In each experiment,
the bacteria were harvested from the surface of
3 MRS agar cultures, with approx. 5 mL of steril-
ized water, and were dispersed properly with a Vor-
tex mixer. 5 mL of bacterial suspension was added
to 10 g (1.5 g PVA, 8.5 g dist. water) of aqueous PVA
solution and 5 g (2.2 g PVP K90, 3.8 g dist. water)
of aqueous PVP K90 solution. In the case of PVP
K30, the polymer (2.25 g) was added directly to the
bacterial suspension (3 mL). Hereinafter they were
mixed properly with magnetic stirrer at 600 rpm
and room temperature. The polymer concentrations
of the obtained suspensions were as follows: PVA:
10 w/w%, PVP K90: 20 w/w%, PVP K30: 45 w/w%.
2.4. Electrospinning
The electrostatic spinner used for the experiments
was equipped with NT-35 High Voltage DC Supply
(MA2000, Nagykanizsa, Hungary). The utilized elec-
trical potential on the spinneret electrode was 35 kV,
which was adjusted during the experiments. A
grounded steel plate covered with polytetrafluoro  -
ethylene was used as collector. Polymer solutions
were dosed by SEP-10S Plus syringe pump (Aitecs,
Vilnius, Lithuania). The distance between the spin-
neret and the collector was 15 cm in all cases and the
experiments were performed at room temperature
(25°C). Electrospinning was carried out in fume
hood. The continuous ventilation provided constant
humidity during the process owing to the same inlet
air. Relative humidity was around 35%, tempera-
ture was 25°C.
2.5. Rheological measurements
Viscosity of the solutions was determined using an
AR 2000 rotational rheometer (TA Instruments, New
Castle, USA) in parallel plate configuration. The
upper moving plate of 40 mm diameter and the lower
Peltier plate, which adjusted the temperature of the
solutions to 25°C, were made of stainless steel.
The viscosities were measured at torques increasing
logarithmically from 10 to 1000 µNm"Pa. The shown
viscosities are the averages of 10 measured values
at different torques (no significant changes were
estimated as a function of torque).
2.6. Scanning electron microscopy (SEM)
Morphology of the samples was investigated with a
JEOL 6380LVa (JEOL, Japan) type scanning elec-
tron microscope. Each specimen was fixed by con-
ductive double sided carbon adhesive tape and sput-
tered by gold (using a JEOL 1200 instrument).
2.7. Viability test
In order to determine the number of colony forming
units in the prepared nanowebs and in the initial
solutions of electrospinning after 4 h, their weighed
pieces were dissolved completely using 5 mL of
sterilized water (stock solution). Hereinafter these
initial solutions were diluted in nine steps (1 step =
10-fold dilution) and after each step 1 mL of solution
was pipetted onto MRS agar plate. Agar plates were
kept in a lockup plastic box containing activated
Microbiology Anaerocult® (Merck, Darmstadt, Ger-
many), which provides anaerobic circumstances by
adsorption of oxygen. These were held at 37°C for
48 hours then the formed colonies were enumerated
(colony forming unit = CFU). CFU number of 1 g
of initial solution was calculated as 100%.
2.8. Storage test
Samples containing LBA were kept in lockup con-
tainers at the typically used storage temperatures (7,
20°C), what correspond to the temperatures of a
freezer and a fridge respectively. Viability of LBA
bacteria in the nanofibers was investigated during
the storage period (3 months) and CFU/g was deter-
mined. The method applied to determine cell viabil-
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bility test part.
2.9. Dissolution test
In order to determine the release time of LBA from
each nanoweb, 100 mg of them were dissolved in
10 mL of dist water. Dissolution vessels were
shaken with a speed of 50 rpm. After 1, 2, 3, 5, 10
and 60 min, 1 mL of the solution was pipetted to an
MRS agar plate and the dissolution media was
refilled with dist. water. The method of plating pro-
cedure was the same that described above. Dissolu-
tion was calculated as follows: the CFU number at
different time points was divided by the total CFU
number at the end of the dissolution test, which was
considered as 100%. The release from membranes
was measured with three samples in each case, and
the relative standard deviations were below 5%.
3. Results and discussion
At first, the electrospinning process of polymers
was optimized without bacteria and the collected
dried products were investigated by SEM. Bacteria
containing polymer solutions were prepared at the
determined optimal concentration. The effect of the
polymers on the viability of the bacteria was exam-
ined as a function of time through 4 h at 25°C. After
that bacteria containing polymer solutions were
electrospun. The obtained morphology was investi-
gated by SEM; the survival rate of the bacteria was
quantified by viability tests. Storage tests of the
electrospun products were also accomplished at two
different temperatures through 3 months.
3.1. Optimization of polymer concentration
Before the encapsulation of LBA, the optimal con-
centrations of polymers in the solution to feed for
electrospinning were determined. The polymers
applicable for pharmaceutical purposes are limited
by stringent regulations. Three different FDA
approved water-soluble polymer types were applied
and compared in this study (PVA, PVP K30 and
PVP K90).
Logarithm of the viscosities of the examined poly-
mer solutions increased nearly linearly with polymer
concentration because of the increasing polymer-
polymer interaction and the growing number of
entanglements [44–46] (Figure 1). The collected solid
particles and fibrous structures were investigated by
scanning electron microscopy. Figure 1 refers to
PVP K30 showing how the morphology changed
from micro- and nanoparticles through beaded fibers
to nanofibers when the concentration and the vis-
cosity of the polymer solution was varied. At lower
(20–30%) polymer concentrations, electrospraying
occurred typically producing submicronic. Electro-
spraying has also capability to encapsulate of bio-
drugs in a very gentle way, which is, however, out
of the scope of this paper.
Beaded fibers were gained from the 35 and 40 w/w%
solution of PVP K30, while at higher concentrations
(45 and 50 w/w%) discrete nano- and microfibers
(~400–2000 nm) were formed owing to the increased
viscosity and higher entanglement of the polymer
chains. Thus, 45 w/w% polymer solution was cho-
sen for the encapsulation of bacteria in the case of
PVP K30.
When the other two polymers were used, the phe-
nomena were similar as in the case of PVP K30
(Figure 1). At lower concentrations, beaded fibers
were gained and the concentrations, which were
found to be optimal for getting discrete fibers with
stable structure were as follows: 10 w/w% in the
case of PVA and 20 w/w% in the case of PVP K90.
Diameters of the formed fibers at the optimal con-
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Figure 1. Viscosities of the PVP K30 of the aqueous solu-
tions and the obtained morphology of objects
electrospun from those solutions
Figure 2. Viscosities of the PVA and PVP K90 aqueous solu-
tions and the obtained morphology at the concen-
trations chosen for the encapsulation of bacteriacentrations were between 150 and 350 nm and 200
and 600 nm in the cases of PVA and PVP K90,
respectively (Figure 2).
3.2. Encapsulation of Lactobacillus
acidophilus into polymer nanofibers
Encapsulation of bacteria was supposed to cause a
significant change in the rheological properties of
the polymer solutions. Consequently, the experi-
ments for encapsulation were started with polymer
concentration at lowest concentration in order to
maintain spinnability.
In contrast to the mentioned concern, the presence of
bacteria in the pumped liquids containing 10  w/w%
PVA and 45 w/w% PVP K30 did not cause any
remarkable changes in the viscosity (increasing of
viscosity was below 0.1 and 0.5%, respectively), only
in the case of 20 w/w% PVP K90 was 3% difference
observed. However it did not affect the fiber forma-
tion during the electrospinning process. The mor-
phology of the LBA bacteria and their arrangement
in electrospun fibers was investigated by scanning
electron microscopy. Figure 3 shows the formed
fibers in different magnifications. These SEM images
enable us to see that the polymer fibers got thicker
by encompassing rod-shaped single or intercon-
nected bacteria. In all cases polymer coating was
formed around bacteria as a result of the ES process.
On the SEM images (Figures 3–6) the sizes of bac-
teria can be seen, which is similar to that of their
original form (width: ~0.5–0.7 µm, length: ~1–
3 µm) that are shown in Figure 6. These results
demonstrate that all the studied pharma-polymers
are capable to encapsulate LBA probiotic bacteria
into water-soluble nanofibers by electrospinning
technique.
Here, the concept of electrospun living bacteria
solid dosage forms containing living bacteria was
put forward using a single fluid electrospinning of
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Figure 3. SEM image of LBA embedded in PVA nanofibers
with thickness data
Figure 4. SEM image of LBA embedded in PVP K30
nanofibers with thickness data
Figure 5. SEM image of LBA embedded in PVP K90
nanofibers with thickness data
Figure 6. SEM image of the applied bacteria with thickness
and length datasuspensions. Coaxial electrospinning [47–49] could
further expand this concept owing to its capability
to manipulate nanostructure.
3.3. Viability results
As the most important issue, from the point of view
of medical application, is the biological activity of
LBA the living bacteria content of the nanofibers
was examined after their dissolution from nano  -
fibers.
Measurement of CFU (colony forming unit) was per-
formed in order to determine the effect of technol-
ogy steps of the whole ES process on bacteria.
Immediately after electrospinning 1 g of nanofibers
still contained large number of active LBA (from
8.78–9.28 logCFU) as the  survival rate of the bac-
teria was between 34 and 68% (Table 1.), which is a
remarkable result compared to efficiency of current
drying processes such as freeze drying and spray
drying. As Rybka and Kailasapathy [50] reported
that recovery of viable Lactobacillus acidophilus
cells after freeze drying was between 1–56% as a
percentage of cells in the original solution. Besides,
Riveros et al. [51] and Wang et al. [52] spray dried
Lactobacillus acido philus under gentle conditions
(inlet temperature: 100°C, outlet temperature: 58,
60°C). Nevertheless, survival rates were only 11
and 4.9% respectively. The better survival rate in
case of PVA can be explained by the oxygen
excluding property of this polymer, which means
that the bacteria are protected during the process
[53].
Viability of LBA bacteria in polymer–containing
suspensions without electrospinning process was
investigated at ambient temperature as a reference.
Number of CFU after 4 h decreased to 79, 72 and
70% (data are not shown) of the initial number in
PVA-, PVP K30- and PVP K90–containing suspen-
sions, respectively. This phenomenon is probably due
to the lack of nutritive in the suspensions and can be
avoided by adding nutrients and stabilizers to the
solution.
Based on these findings electrospinning is a capable
technique to produce solid dosage form of LBA in a
gentle way.
3.4. Stability results
Table 2 presents the result of stability tests in case
of three different of polymers. Keeping samples at
ambient temperature caused the total loss of biolog-
ical activity of them after a week (data are not
shown). This result was predictable because mar-
keted biopharmaceutical products containing living
organism have to be stored generally at 2–8°C. The
difference between the stability of samples stored at
7 and –20°C is very slight suggesting that both stor-
age conditions are applicable and freezing is proba-
bly not necessary in most cases. Stability tests also
confirmed that all of the selected polymer solutions,
having no significant effect on viability of LBA, are
applicable for living cell formulation. After 90 days,
nanofibers still contained large amounts of LBA,
which is a remarkable achievement considering the
fact that there was no stabilizer of LBA present.
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Table 1. Number of active bacteria and survival rate in dif-
ferent types of electrospun nanowebs
Initial solution
log (CFU/g)
Electrospun
biohybrid nanoweb
log (CFU/g)
Survival
[%]
PVA 9.45±0.03 9.28±0.03 68
PVP K30 9.12±0.04 8.65±0.04 34
PVP K90 9.18±0.03 8.78±0.04 40
Table 2. Number of colony forming units per grams of electrospun nanofibers as a function of time at two temperatures
Time
[days]
0 7 30 90
PVA (7°C)
log(CFU/g) 9.28±0.03 8.72±0.02 8.34±0.03 7.97±0.05
% 100 27 11 4,9
PVA (–20°C)
log(CFU/g) 9.28±0.03 8.49±0.03 8.29±0.05 8.09±0.03
% 100 16 10 6,4
PVP K30 (7°C)
log(CFU/g) 8.65±0.04 7.94±0.06 7.55±0.04 7.07±0.04
% 100 19 7,9 2,6
PVP K30 (–20°C)
log(CFU/g) 8.65±0.04 8.28±0.04 7.88±0.03 7.58±0.03
% 100 42 17 8,5
PVP K90 (7°C)
log(CFU/g) 8.78±0.04 8.11±0.03 7.72±0.06 7.24±0.05
% 100 21 8,8 2,9
PVP K90 (–20°C)
log(CFU/g) 8.78±0.04 8.35±0.05 7.95±0.03 7.64±0.04
% 100 37 14 7.2Applying stabilizer and packaging that excludes the
oxygen would probably further improve the stabil-
ity of living LBA [54].
3.5. Potential dosage forms of LBA containing
biohybrid nanoweb
Industrial scaling-up of the described process seems
to be achievable based on recent developments in
the field of electrospinning. Several solutions for
industrial-scale production of electrospun nanofibers
are available and used mainly in the filtration indus-
try [55]. Industrially performed electrospinning,
equipped with transferring collector, is continuous
process having very low energy consumption and
high enough capacity to fabricate pharmaceutical
products. As the developed electrospun BNW con-
tain, according to the viability and stability results,
high enough amounts of biologically active probi-
otic bacteria, several novel and existing pharmaceu-
tical dosage forms can be designed on this basis.
PVA and PVP have already been applied in vaginal
formulations [56]; thus, vaginal film or electrospun
biohybrid nanoweb of these polymers, containing
LBA, can easily get approval from the authorities.
In order to use the new living-cell-containing solid
materials for curing bacterial vaginosis, selection of
administration in adequate form is also necessary.
The simplest way is to apply the prepared non-
woven tissue directly after the removal from the col-
lector and cutting into proper-sized (proper-weight)
pieces. The square-cut webs can be delivered manu-
ally into the vagina (similarly to the insertion of
vaginal contraceptive films called VCF), where the
inserted web dissolves. For this kind of administra-
tion PVA- and PVP K90-based biohybrid nanowebs
with mucoadhesive character [57, 58] are preferred
and some kind of applicator (tweezers, protective
gloves, etc.) needs to avoid the dissolution of web
before placement. These nanofibrous tissues can be
attached to a carrier film containing enhancer addi-
tives. The multilayer system, adhered to the mucosa,
releases the bacteria as the polymer dissolves.
Furthermore, all kinds of nanowebs prepared in this
work, dissolved instantly when they got in contact
with water, and can be well exploited in stabile for-
mulation. On Figure 7 saturation curves show that
nearly the total (90%) amount of bacteria were
released within one minute and there was no signif-
icant difference between the polymers due to the
huge surface and to the good solubility of nano  -
fibers.
After the rapid dissolution of the solid BNW, the
obtained LBA-containing liquid is administrable as
a douche and can be effective against bacterial vagi-
nosis owing to the high active probiotic content.
Further enhancement of curing efficiency can be
achieved by introducing appropriate excipients
such as lactose, lactic acid and buffering salts, in the
solvent of the web. As the nanofibrous matrix dis-
solves instantly when contacting with water, it can
also be filled in disposable syringes together with
excipients, buffering agents and enhancers which
can be injected after rapid dissolution in water
loaded in the syringe.
4. Conclusions
The present work shows that electrospinning is a
capable way for stable solid formulation of LBA. It
was found that with all the three studied polymers
solutions were suitable for encapsulating huge
amounts of LBA and provided long shelf life at 7
and 20°C, which can be even further extended using
stabilizer excipients or applying oxygen excluding
packaging. The formed nanofibrous product can be
applied as an inexpensive and easy-to-use dosage
form that can be recommended for the treatment of
bacterial vaginosis. An adequate dose of living bac-
teria could be stabilized using this effective and
gentle technique, which is considered to be a feasi-
ble way to produce other biopharmaceuticals as
well. The dosage forms (e.g. vaginal douche) based
on the developed biohybrid nanowebs are new
potential way for curing bacterial vaginosis.
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Figure 7. Release of LBA from different polymers (PVA,
PVP K30, PVP K90) based BNWsAcknowledgements
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